SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is trending amid extreme volatility and a significant price decline, with many in the community citing aggressive market 'manipulation' or 'fkkery'. Despite some expectations for a 'polar payday' driven by potential colder weather, the leveraged ETF faces relentless selling pressure, prompting discussions of capitulation, impending reverse splits, and its inherent decay as it tracks natural gas futures.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending due to recent policy moves aimed at driving down mortgage rates, which has ignited strong community optimism for a revitalized housing market. Investors are actively discussing the potential for increased transaction volume and a significant price appreciation, with many anticipating a move towards double-digit levels for the company's stock.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending amid buzz over its strategic agreement with Meta Platforms to power AI data centers and a U.S. Department of Energy deal for a radioisotope pilot facility. The community is intensely discussing whether the company's long-term potential in advanced nuclear energy, bolstered by government initiatives and AI's immense power needs, outweighs its current lack of commercial revenue. Anticipation builds around an upcoming congressional hearing on nuclear energy dominance, which investors believe could further accelerate its market position.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics is generating significant buzz as its pivotal PDUFA date for Anaphylm rapidly approaches, with many anticipating a potential game-changing approval for the device-free epinephrine film. Community discussion highlights Anaphylm's unique convenience and the FDA waiving an Advisory Committee meeting as strong positive signals, while a substantial short interest fuels speculation of an impending squeeze. Conversely, some investors remain cautious, weighing past regulatory challenges against the promise of a novel, needle-free allergy treatment.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is actively trending as it solidifies strategic nuclear energy partnerships with companies like Vistra and Oklo, a move critically observed by the community as indispensable for powering its ambitious AI data center expansion. This development highlights the escalating energy demands of the AI race, prompting discussions among investors about Meta's long-term vision and its ability to execute. Additionally, China's review of Meta's Manus AI acquisition is generating buzz, adding a layer of geopolitical interest to the company's recent activities.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is trending amidst heightened discussions regarding the critical role of Small Modular Reactors in meeting the escalating energy demands from AI data centers and broader market needs. The community is actively debating the company's long-term potential as the sole NRC-approved SMR provider, with bulls pointing to anticipated government support and contracts, while others express caution regarding its pre-revenue state and historical volatility. This positions NuScale Power within a broader conversation about the future of energy infrastructure for next-generation technology.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

ASP Isotopes is trending after securing all regulatory approvals for its Renergen acquisition, which expands its portfolio into helium and LNG alongside its core isotope business. The community is actively discussing this, alongside a recent "Overweight" rating from Cantor Fitzgerald, as ASPI aims to be a critical supplier of HALEU and specialized isotopes for the growing nuclear and tech sectors.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, Sunset, and Asset Closure. The Retail segment sells electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Sunset segment includes generation plants with announced retirement plans. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Vistra Corp (VST) is trending as it aggressively expands its power generation capacity, notably with a $4 billion acquisition of Cogentrix Energy's natural gas fleet, directly addressing the surging electricity demand from AI data centers. This strategic move, complementing earlier nuclear power contracts, positions Vistra as a pivotal supplier for hyperscalers, with the community actively debating its role in solving the critical 'AI energy bottleneck' amid recent market volatility.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (MLTX) is trending following overwhelmingly positive feedback from its FDA Type B meeting, confirming a clear path for its sonelokimab (SLK) Biologics License Application (BLA) in hidradenitis suppurativa without additional clinical trials. This significant de-risking event has ignited strong optimism among investors, who anticipate substantial analyst upgrades and a renewed focus on potential acquisition by larger pharmaceutical companies, particularly given SLK's strong position in the immunology market. Community discussions highlight the belief that the stock is fundamentally undervalued, expecting a significant re-rating as regulatory clarity and strategic appeal of the asset drive conversation.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

Terrestrial Energy (IMSR) is trending following its pivotal agreement with the U.S. Department of Energy for Project TETRA, a pilot reactor initiative accelerating its advanced molten salt reactor technology. This development has ignited community discussion comparing IMSR's potential to other advanced nuclear peers like $OKLO, with many anticipating its role in meeting growing energy demands from industrial and AI sectors, believing this government backing de-risks its path to commercialization.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DSGN Design Therapeutics Announces Start of Friedreich Ataxia Patient Dosing Ex-U.S. in its RESTORE-FA Phase 1/2 Multiple-Ascending Dose Trial of DT-216P2

Vistrix

StockTwits Web

Design Therapeutics Inc

 Design Therapeutics Announces Start of Friedreich Ataxia Patient Dosing Ex-U.S. in its RESTORE-FA Phase 1/2 Multiple-Ascending Dose Trial of DT-216P2